Understand the source comparison
LIPO-C Safe Side Effects: Full Comparison
Injection site reaction (erythema, tenderness) 15–30% per dose Local inflammatory cytokine release (IL-1β, IL-6) at injection site Mild. Resolves within 24 hours Rotate injection sites, use 25–27 gauge needle, inject slowly Expected and manageable with proper
No winner is assigned.
This page preserves a source comparison for education. It does not add a rating, recommendation or clinical judgment.
- Injection site reaction (erythema, tenderness)
- 15–30% per dose
- Local inflammatory cytokine release (IL-1β, IL-6) at injection site
- Mild. Resolves within 24 hours
- Rotate injection sites, use 25–27 gauge needle, inject slowly
- Expected and manageable with proper technique
- Gastrointestinal discomfort (nausea, cramping)
- 8–12% of subjects
- Homocysteine accumulation during methionine metabolism
- Mild to moderate. Transient
- Co-administer methylcobalamin and methylfolate to support homocysteine remethylation
- More common in MTHFR variant carriers
- Allergic reaction (urticaria, pruritus)
- <5% of subjects
- Histamine release triggered by choline bitartrate or preservatives
- Mild (urticaria) to severe (angioedema)
- Screen for tartrate sensitivity, use preservative-free formulations
- Rare but requires immediate protocol adjustment
- Fishy body odor
- 2–5% at high doses
- Trimethylamine production from excess choline, converted to TMAO by gut bacteria
- Mild. Cosmetic only
- Reduce choline dose or increase dosing interval
- Occurs only at supraphysiologic choline levels
- Formulation contamination effects (fever, severe site reaction)
- Variable (0.5–8% with non-validated sourcing)
- Bacterial endotoxins, particulate matter, pH instability in impure preparations
- Moderate to severe
- Source from FDA-registered 503B facilities with CoA verification
- Completely preventable with proper sourcing